Diabetes due to Mitochondrial Adipopathy

Affiliations

Comment

Hiroyo Ninomiya et al. Intern Med. 2017.

. 2017;56(6):745.

doi: 10.2169/internalmedicine.56.7950. Epub 2017 Mar 17.

¹ Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan.

No abstract available

Comment on

Treatment of Mitochondrial Diabetes with a Peroxisome Proliferator-activated Receptor (PPAR)-gamma Agonist.
Ninomiya H, Hirata A, Kozawa J, Nakata S, Kimura T, Kitamura T, Yasuda T, Otsuki M, Imagawa A, Kaneto H, Funahashi T, Shimomura I. Ninomiya H, et al. Intern Med. 2016;55(9):1143-7. doi: 10.2169/internalmedicine.55.4418. Epub 2016 May 1. Intern Med. 2016. PMID: 27150869
Diabetes due to Mitochondrial Adipopathy.
Finsterer J, Frank M. Finsterer J, et al. Intern Med. 2017;56(6):747. doi: 10.2169/internalmedicine.56.7750. Epub 2017 Mar 17. Intern Med. 2017. PMID: 28321085 Free PMC article. No abstract available.

1. Ninomiya H, Hirata A, Kozawa J, et al. . Treatment of mitochondrial diabetes with a peroxisome proliferator-activated receptor (PPAR)-gamma agonist. Intern Med 55: 1143-1147, 2016. - PubMed
1. Baden MY, Yamada Y, Takahi Y, et al. . A case of mitochondrial kidney disease with insulin resistance and hypoadiponectinemia. Diabetol Int 3: 54-60, 2012.